Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Daily Top 10 COVID-19 papers DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM

Vaccines

Free Subscription Articles published in Pediatr Infect Dis J Retrieve available abstracts of 132 articles: HTML format

Single Articles

May 2020
1. HAN Y, Chen Z, Zheng K, Li X, et al
   Epidemiology of Hand, Foot, and Mouth Disease Before and After the Introduction of Enterovirus 71 Vaccines in Chengdu, China, 2009-2018.
   Pediatr Infect Dis J. 2020 May 19. doi: 10.1097/INF.0000000000002745.
   PubMed     Abstract available
   
   
   
2. PALMU AA, Rinta-Kokko H, Nohynek H, Nuorti JP, et al
   Indirect Impact of Ten-valent Pneumococcal Conjugate Vaccine Program on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland.
   Pediatr Infect Dis J. 2020 May 13. doi: 10.1097/INF.0000000000002696.
   PubMed     Abstract available
   
   
   
3. ESPOSITO S, Fling J, Chokephaibulkit K, de Bruijn M, et al
   Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Seasonal Influenza Vaccine in Young Children at High Risk of Influenza-associated Complications: A Phase III, Randomized, Observer-blind, Multicenter Clinical Trial.
   Pediatr Infect Dis J. 2020 May 12. doi: 10.1097/INF.0000000000002727.
   PubMed     Abstract available
   
   
   
4. HEININGER U
   Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
   Pediatr Infect Dis J. 2020 May 11. doi: 10.1097/INF.0000000000002741.
   PubMed    
   
   
   
5. 
   Comparative Assessment of a Single Dose and a 2-dose Vaccination Series of a Quadrivalent Meningococcal CRM-conjugate Vaccine (MenACWY-CRM) in Children 2-10 Years of Age: ERRATUM.
   Pediatr Infect Dis J. 2020 May 5. doi: 10.1097/INF.0000000000002753.
   PubMed    
   
   
   
6. KURODA N
   Demand for BCG Vaccine Due to Unproven Claims of its Role in Preventing COVID-19 Is Causing Shortages of Vaccines for Infants in Japan.
   Pediatr Infect Dis J. 2020 May 5. doi: 10.1097/INF.0000000000002724.
   PubMed    
   
   
   
7. ARORA NK, Das MK, Poluru R, Kashyap NK, et al
   A Prospective Cohort Study on the Safety of Infant Pentavalent (DTwP-HBV-Hib) and Oral Polio Vaccines in Two South Indian Districts.
   Pediatr Infect Dis J. 2020;39:389-396.
   PubMed     Abstract available
   
   
   
8. ZIMMERMANN P, Curtis N
   Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children.
   Pediatr Infect Dis J. 2020;39:355-368.
   PubMed     Abstract available
   
   
   April 2020
9. DELAHOY MJ, Carcamo C, Ordonez L, Vasquez V, et al
   Impact of Rotavirus Vaccination Varies by Level of Access to Piped Water and Sewerage: An Analysis of Childhood Clinic Visits for Diarrhea in Peru, 2005-2015.
   Pediatr Infect Dis J. 2020 Apr 23. doi: 10.1097/INF.0000000000002702.
   PubMed     Abstract available
   
   
   
10. SRICHAROENCHAI S, Kerr SJ, Gatechompol S, Hansudewechakul R, et al
    Prevalence of High-risk Nonavalent Vaccine-type Human Papillomavirus Infection Among Unvaccinated, Sexually Active Asian Female Adolescents With and Without Perinatally Acquired HIV Infection.
    Pediatr Infect Dis J. 2020 Apr 8. doi: 10.1097/INF.0000000000002659.
    PubMed     Abstract available
    
    
    March 2020
11. MARQUIS A, Koch J
    Impact of Routine Rotavirus Vaccination in Germany: Evaluation Five Years After Its Introduction.
    Pediatr Infect Dis J. 2020 Mar 13. doi: 10.1097/INF.0000000000002656.
    PubMed     Abstract available
    
    
    
12. HAUSE AM, Hesse EM, Ng C, Marquez P, et al
    Association Between Vaccine Exemption Policy Change in California and Adverse Event Reporting.
    Pediatr Infect Dis J. 2020 Mar 5. doi: 10.1097/INF.0000000000002585.
    PubMed     Abstract available
    
    
    
13. COPELYN J, Hincks JR, Wilmshurst JM, Petersen W, et al
    Clearance of Immunodeficiency-associated Vaccine-derived Poliovirus Infection With Pocapavir.
    Pediatr Infect Dis J. 2020 Mar 2. doi: 10.1097/INF.0000000000002584.
    PubMed     Abstract available
    
    
    
14. WONG NX, Buttery J, McMinn A, Azhar Z, et al
    Safety of the Polish BCG-10 Vaccine During a Period of BCG Vaccine Shortage: An Australian Experience.
    Pediatr Infect Dis J. 2020 Mar 2. doi: 10.1097/INF.0000000000002630.
    PubMed     Abstract available
    
    
    
15. NEWCOMER SR, Daley MF, Narwaney KJ, Xu S, et al
    Order of Live and Inactivated Vaccines and Risk of Non-vaccine-targeted Infections in US Children 11-23 Months of Age.
    Pediatr Infect Dis J. 2020;39:247-253.
    PubMed     Abstract available
    
    
    
16. DEMBINSKI L, Krzesiek E, Klincewicz B, Grzybowska-Chlebowczyk U, et al
    Immunogenicity of Diphtheria Booster Vaccination in Adolescents With Inflammatory Bowel Disease.
    Pediatr Infect Dis J. 2020;39:244-246.
    PubMed     Abstract available
    
    
    February 2020
17. SHARMA K, Perrett KP, Wood N
    CASE SERIES: YELLOW FEVER VACCINATION IN EGG-ALLERGIC CHILDREN.
    Pediatr Infect Dis J. 2020 Feb 28. doi: 10.1097/INF.0000000000002625.
    PubMed     Abstract available
    
    
    
18. REYNALES H, Carrasquilla G, Zambrano B, Cortes S M, et al
    Secondary Analysis of the Efficacy and Safety Trial Data of the Tetravalent Dengue Vaccine in Children and Adolescents in Colombia.
    Pediatr Infect Dis J. 2020 Feb 7. doi: 10.1097/INF.0000000000002580.
    PubMed     Abstract available
    
    
    
19. DETTY SQ, Peebles JK, Guerrieri JM, Seroogy CM, et al
    Vaccine-Strain Herpes Zoster Ophthalmicus in a 14-month-old Boy Prompting an Immunodeficiency Workup: Case Report and Review of Vaccine-strain Herpes Zoster.
    Pediatr Infect Dis J. 2020;39:e25-e27.
    PubMed     Abstract available
    
    
    
20. FAHRNI O, Posfay-Barbe KM, Wagner N
    Immunization Against Hepatitis A in Migrant Children: Three Vaccination Strategies, A Retrospective Study.
    Pediatr Infect Dis J. 2020;39:164-169.
    PubMed     Abstract available
    
    
    January 2020
21. CHO H, Lee H, Kim DS, Kim HM, et al
    Socioeconomic Impact of the Rotavirus Vaccine in Korea: Comparing the Epidemiologic and Economic Characteristics of Rotavirus Gastroenteritis Before and After the Introduction of Vaccines.
    Pediatr Infect Dis J. 2020 Jan 24. doi: 10.1097/INF.0000000000002582.
    PubMed     Abstract available
    
    
    
22. KAWABATA T, Tenokuchi Y, Yamakuchi H, Sameshima H, et al
    Concurrent Bacteremia Due to Non-vaccine Serotype 24F Pneumococcus in Twins: A Rapid Increase in Serotype 24F-invasive Pneumococcal Disease and its High Invasive Potential.
    Pediatr Infect Dis J. 2020;39:85-87.
    PubMed     Abstract available
    
    
    
23. DUBUS M, Ladhani S, Vasu V
    Prophylactic Paracetamol After Meningococcal B Vaccination Reduces Postvaccination Fever and Septic Screens in Hospitalized Preterm Infants.
    Pediatr Infect Dis J. 2020;39:78-80.
    PubMed     Abstract available
    
    
    December 2019
24. KEECH CA, Morrison R, Anderson P, Tate A, et al
    A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults.
    Pediatr Infect Dis J. 2019 Dec 27. doi: 10.1097/INF.0000000000002567.
    PubMed     Abstract available
    
    
    
25. WILLAME C, Gadroen K, Bramer W, Weibel D, et al
    Systematic Review and Meta-analysis of Postlicensure Observational Studies on Human Papillomavirus Vaccination and Autoimmune and Other Rare Adverse Events.
    Pediatr Infect Dis J. 2019 Dec 20. doi: 10.1097/INF.0000000000002569.
    PubMed     Abstract available
    
    
    
26. CORCORAN M, Mereckiene J, Cotter S, Murchan S, et al
    Invasive Streptococcus pneumoniae Infections and Vaccine Failures in Children in Ireland From the Postvaccine Era From 2007 to 2018.
    Pediatr Infect Dis J. 2019 Dec 2. doi: 10.1097/INF.0000000000002549.
    PubMed     Abstract available
    
    
    
27. CHURCH JA, Rogawski McQuade ET, Mutasa K, Taniuchi M, et al
    Enteropathogens and Rotavirus Vaccine Immunogenicity in a Cluster Randomized Trial of Improved Water, Sanitation and Hygiene in Rural Zimbabwe.
    Pediatr Infect Dis J. 2019;38:1242-1248.
    PubMed     Abstract available
    
    
    November 2019
28. XIE J, Zhang Y, Caro-Aguilar I, Indrawati L, et al
    Immunogenicity Comparison of a Next Generation Pneumococcal Conjugate Vaccine in Animal Models and Human Infants.
    Pediatr Infect Dis J. 2019 Nov 7. doi: 10.1097/INF.0000000000002522.
    PubMed     Abstract available
    
    
    
29. BLOOM DE, Kirby PN, Pugh S, Stawasz A, et al
    COMMENTARY: WHY HAS UPTAKE OF PNEUMOCOCCAL VACCINES FOR CHILDREN BEEN SO SLOW? THE PERILS OF UNDERVALUATION.
    Pediatr Infect Dis J. 2019 Nov 7. doi: 10.1097/INF.0000000000002521.
    PubMed     Abstract available
    
    
    
30. DBAIBO G, Amanullah A, Claeys C, Izu A, et al
    Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial.
    Pediatr Infect Dis J. 2019 Nov 5. doi: 10.1097/INF.0000000000002504.
    PubMed     Abstract available
    
    
    
31. ZHU F, Hu Y, Li J, Ye Q, et al
    Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine Administered in a 3 + 1 versus 2 + 1 Dose Schedule Among Infants in China.
    Pediatr Infect Dis J. 2019;38:1150-1158.
    PubMed     Abstract available
    
    
    September 2019
32. JAYASINGHE S, Liu B, Gidding H, Gibson A, et al
    Long-term Vaccine Impact on Invasive Pneumococcal Disease Among Children With Significant Comorbidities in a Large Australian Birth Cohort.
    Pediatr Infect Dis J. 2019;38:967-973.
    PubMed     Abstract available
    
    
    August 2019
33. LIN L, Macias Parra M, Sierra VY, Salas Cespedes A, et al
    Long-term Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus-16/18 Vaccine in Four- to Six-year-old Girls: Three-year Follow-up of a Randomized Phase III Trial.
    Pediatr Infect Dis J. 2019 Aug 28. doi: 10.1097/INF.0000000000002437.
    PubMed     Abstract available
    
    
    
34. EDWARDS K, Lambert PH, Black S
    Narcolepsy and Pandemic Influenza Vaccination: What We Need to Know to be Ready for the Next Pandemic.
    Pediatr Infect Dis J. 2019;38:873-876.
    PubMed     Abstract available
    
    
    
35. DANIER J, Rivera L, Claeys C, Dbaibo G, et al
    Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine.
    Pediatr Infect Dis J. 2019;38:866-872.
    PubMed     Abstract available
    
    
    July 2019
36. MEJIAS A, Rodriguez-Fernandez R, Peeples ME, Ramilo O, et al
    Respiratory Syncytial Virus Vaccines: Are We Making Progress?
    Pediatr Infect Dis J. 2019 Jul 18. doi: 10.1097/INF.0000000000002404.
    PubMed    
    
    
    
37. EUN BW, Lee TJ, Lee J, Kim KH, et al
    A Randomized, Double-blind, Active-controlled Phase III Trial of a Cell Culture-derived Quadrivalent Inactivated Influenza Vaccine in Healthy South Korean Children and Adolescents 6 Months to 18 Years of Age.
    Pediatr Infect Dis J. 2019 Jul 16. doi: 10.1097/INF.0000000000002406.
    PubMed     Abstract available
    
    
    
38. CHANTHAVANICH P, Anderson E, Kerdpanich P, Bulitta M, et al
    Safety, Tolerability and Immunogenicity of an MF59-adjuvanted, Cell Culture-derived, A/H5N1, Subunit Influenza Virus Vaccine: Results From a Dose-finding Clinical Trial in Healthy Pediatric Subjects.
    Pediatr Infect Dis J. 2019;38:757-764.
    PubMed     Abstract available
    
    
    
39. YOUSAFZAI MT, Riaz A, Omer SB, Husain S, et al
    Development and Validation of Parental Vaccine Attitudes Scale for Use in Low-income Setting.
    Pediatr Infect Dis J. 2019;38:e143-e148.
    PubMed     Abstract available
    
    
    June 2019
40. RIVERO I, Raguindin PF, Buttler R, Martinon-Torres F, et al
    False Vaccine Contraindications Among Healthcare Providers in Europe: A Short Survey Among Members of The European Society of Pediatric Infectious Diseases.
    Pediatr Infect Dis J. 2019 Jun 21. doi: 10.1097/INF.0000000000002401.
    PubMed     Abstract available
    
    
    
41. MITCHELL HK, Mokomane M, Leeme T, Tlhako N, et al
    Causes of Pediatric Meningitis in Botswana: Results From a 16-Year National Meningitis Audit.
    Pediatr Infect Dis J. 2019 Jun 21. doi: 10.1097/INF.0000000000002396.
    PubMed     Abstract available
    
    
    
42. HUBICHE T, Brazier C, Vabret A, Reynaud S, et al
    MEASLES TRANSMISSION IN A FULLY VACCINATED CLOSED COHORT: Data From a Nosocomial Clustered Cases in a Teenage Psychiatric Unit.
    Pediatr Infect Dis J. 2019 Jun 20. doi: 10.1097/INF.0000000000002372.
    PubMed     Abstract available
    
    
    
43. WILCOX CR, Calvert A, Metz J, Kilich E, et al
    Attitudes of Pregnant Women and Healthcare Professionals Toward Clinical Trials and Routine Implementation of Antenatal Vaccination Against Respiratory Syncytial Virus: A Multicenter Questionnaire Study.
    Pediatr Infect Dis J. 2019 Jun 20. doi: 10.1097/INF.0000000000002384.
    PubMed     Abstract available
    
    
    
44. NOLAN T, Booy R, Marshall HS, Richmond P, et al
    Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as Toddlers.
    Pediatr Infect Dis J. 2019;38:643-650.
    PubMed     Abstract available
    
    
    
45. CHIU M, Bao C, Sadarangani M
    Dilemmas With Rotavirus Vaccine: The Neonate and Immunocompromised.
    Pediatr Infect Dis J. 2019;38.
    PubMed     Abstract available
    
    
    
46. SCHEIFELE DW
    Will Infant Hepatitis B Immunization Protect Adults?
    Pediatr Infect Dis J. 2019;38.
    PubMed     Abstract available
    
    
    May 2019
47. HEMMING-HARLO M, Lahdeaho ML, Maki M, Vesikari T, et al
    Rotavirus Vaccination Does Not Increase Type 1 Diabetes and May Decrease Celiac Disease in Children and Adolescents.
    Pediatr Infect Dis J. 2019;38:539-541.
    PubMed     Abstract available
    
    
    
48. CORONEL D, Garcia-Rivera EJ, Rivera M, Arredondo-Garcia JL, et al
    Dengue Vaccine Booster in Healthy Adolescents and Adults in Latin America: Evaluation 4-5 Years After a Primary 3-Dose Schedule.
    Pediatr Infect Dis J. 2019;38:e90-e95.
    PubMed     Abstract available
    
    
    April 2019
49. MAKGATHO E, Patel F, Solomon F, Groome MJ, et al
    The Burden of Acute Diarrheal Disease in Young Hospitalized Urban South African Children Five Years After Rotavirus Vaccine Introduction: A Retrospective Descriptive Study.
    Pediatr Infect Dis J. 2019 Apr 10. doi: 10.1097/INF.0000000000002304.
    PubMed     Abstract available
    
    
    
50. GIDDING HF, Sheridan S, Fathima P, Moore HC, et al
    Impact of Childhood Pneumococcal Conjugate Vaccine on Nonnotified Clinically Suspected Invasive Pneumococcal Disease in Australia.
    Pediatr Infect Dis J. 2019 Apr 10. doi: 10.1097/INF.0000000000002314.
    PubMed     Abstract available
    
    
    
51. SLACK M, Vyse A, Madhava H, Reinert RR, et al
    Ongoing Exposure of U.K. Infants to Vaccine Serotype Pneumococci.
    Pediatr Infect Dis J. 2019;38:444.
    PubMed    
    
    
    
52. GROSSMAN Z, Hadjipanayis A, Degani A, Somekh E, et al
    Tracking Changes in Vaccine Attitudes and Decisions: Results from 2008 and 2016 Parental Surveys.
    Pediatr Infect Dis J. 2019;38:e75-e76.
    PubMed     Abstract available
    
    
    
53. XU J, Stek JE, Ziani E, Liu GF, et al
    Integrated Safety Profile of a New Approved, Fully Liquid DTaP5-HB-IPV-Hib Vaccine.
    Pediatr Infect Dis J. 2019;38:439-443.
    PubMed     Abstract available
    
    
    
54. MOODLEY K, Coovadia YM, Cohen C, Meiring S, et al
    Invasive Pneumococcal Disease in Neonates Prior to Pneumococcal Conjugate Vaccine Use in South Africa: 2003-2008.
    Pediatr Infect Dis J. 2019;38:424-430.
    PubMed     Abstract available
    
    
    
55. FARNAES L, Coufal NG, Spector SA
    Vaccine Strain Varicella Infection in an Infant With Previously Undiagnosed Perinatal Human Immunodeficiency Type-1 Infection.
    Pediatr Infect Dis J. 2019;38:413-415.
    PubMed     Abstract available
    
    
    March 2019
56. STEIN-ZAMIR C, Sokolov I, Abramson N, Shoob H, et al
    Pertussis Outbreak in Infants and an Immunization Campaign Based on Providing Pertussis Vaccine Doses at 6 Weeks, 10 Weeks, and 14 Weeks.
    Pediatr Infect Dis J. 2019;38:e63-e64.
    PubMed    
    
    
    February 2019
57. CURTIS N
    BCG Vaccination and All-Cause Neonatal Mortality.
    Pediatr Infect Dis J. 2019;38:195-197.
    PubMed    
    
    
    January 2019
58. KING LM, Bartoces M, Hersh AL, Hicks LA, et al
    National Incidence of Pediatric Mastoiditis in the United States, 2000-2012: Creating a Baseline for Public Health Surveillance.
    Pediatr Infect Dis J. 2019;38:e14-e16.
    PubMed     Abstract available
    
    
    December 2018
59. PLOTKIN SA, Offit PA, Reiss D
    Important New Resource for Clinicians Giving Expert Witness Testimony on Vaccines.
    Pediatr Infect Dis J. 2018;37:e353.
    PubMed    
    
    
    
60. PALMU AA, Lahdenkari M
    Re: "First Otitis Media and Pneumococcal Conjugate Vaccine Serotypes in Infants".
    Pediatr Infect Dis J. 2018;37:e352-e353.
    PubMed    
    
    
    
61. DAGAN R, Pelton S, Bakaletz L, Cohen R, et al
    First Otitis Media and Pneumococcal Conjugate Vaccine Serotypes in Infants.
    Pediatr Infect Dis J. 2018;37:e351-e352.
    PubMed    
    
    
    November 2018
62. XU J, Stek JE, Ziani E, Liu GF, et al
    Integrated Safety Profile of a New Approved, Fully-liquid DTaP5-HB-IPV-Hib Vaccine.
    Pediatr Infect Dis J. 2018 Nov 27. doi: 10.1097/INF.0000000000002257.
    PubMed     Abstract available
    
    
    
63. WILCOX CR, Calvert A, Metz J, Kilich E, et al
    Determinants of Influenza and Pertussis Vaccination Uptake in Pregnancy: A Multi-Centre Questionnaire Study of Pregnant Women and Healthcare Professionals.
    Pediatr Infect Dis J. 2018 Nov 9. doi: 10.1097/INF.0000000000002242.
    PubMed     Abstract available
    
    
    
64. SPOULOU V, Alain S, Gabutti G, Giaquinto C, et al
    Implementing Universal Varicella Vaccination in Europe: The Path Forward.
    Pediatr Infect Dis J. 2018 Nov 7. doi: 10.1097/INF.0000000000002233.
    PubMed     Abstract available
    
    
    
65. MARTINON-TORRES F, Diez-Domingo J, Feroldi E, Jordanov E, et al
    Evaluation of a Hexavalent-Pentavalent-Hexavalent Infant Primary Vaccination Series Followed by a Pentavalent Booster Vaccine in Healthy Infants and Toddlers.
    Pediatr Infect Dis J. 2018 Nov 7. doi: 10.1097/INF.0000000000002231.
    PubMed     Abstract available
    
    
    
66. ROBERTSON CA, Mercer M, Selmani A, Klein NP, et al
    Safety and Immunogenicity of a Full-Dose Split-Virion Inactivated Quadrivalent Influenza Vaccine in Healthy Children 6 to 35 Months of Age: A Randomized Controlled Clinical Trial.
    Pediatr Infect Dis J. 2018 Nov 2. doi: 10.1097/INF.0000000000002227.
    PubMed     Abstract available
    
    
    
67. CORTES M, Lopez P, Marquez V, Cortes C, et al
    Safety Follow-up of a Dengue Vaccine When Administered Concomitantly with a Yellow Fever Vaccine in Healthy Toddlers in Colombia.
    Pediatr Infect Dis J. 2018;37:1190-1191.
    PubMed     Abstract available
    
    
    October 2018
68. CLAEYS C, Chandrasekaran V, Garcia-Sicilia J, Prymula R, et al
    Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naive Children.
    Pediatr Infect Dis J. 2018 Oct 15. doi: 10.1097/INF.0000000000002217.
    PubMed     Abstract available
    
    
    
69. SIGAUQUE B, Moiane B, Massora S, Pimenta F, et al
    Early Declines in Vaccine Type Pneumococcal Carriage in Children Less Than 5 Years Old After Introduction of 10-valent Pneumococcal Conjugate Vaccine in Mozambique.
    Pediatr Infect Dis J. 2018;37:1054-1060.
    PubMed     Abstract available
    
    
    
70. WALLS T, Cho V, Martin N, Williman J, et al
    Vaccine Impact on Long-term Trends in Invasive Bacterial Disease in New Zealand Children.
    Pediatr Infect Dis J. 2018;37:1041-1047.
    PubMed     Abstract available
    
    
    September 2018
71. JAYARAMAN K, Adhisivam B, Nallasivan S, Krishnan RG, et al
    Two Randomized Trials of the Effect of BCG-Russia Alone or With Oral Polio Vaccine on Neonatal Mortality in Infants Weighing <2000 G in India.
    Pediatr Infect Dis J. 2018 Sep 25. doi: 10.1097/INF.0000000000002198.
    PubMed     Abstract available
    
    
    
72. FARNAES L, Coufal N, Spector SA
    Vaccine Strain Varicella Infection in an Infant with Previously Undiagnosed Perinatal Human Immunodeficiency Type-1 Infection.
    Pediatr Infect Dis J. 2018 Sep 7. doi: 10.1097/INF.0000000000002183.
    PubMed     Abstract available
    
    
    August 2018
73. OLSON D, Rick AM, Krager S, Lamb M, et al
    Vaccine Demand and Willingness-to-Pay for Arbovirus Vaccines: A Cross Sectional Survey in Rural Guatemala.
    Pediatr Infect Dis J. 2018 Aug 27. doi: 10.1097/INF.0000000000002169.
    PubMed     Abstract available
    
    
    
74. MBUTHIA JK, Kabera BM, Karuga R, Ivui G, et al
    A Cross-sectional Study to Compare Hepatitis B Immunity in HIV-infected and HIV-uninfected Kenyan Children After Primary Hepatitis B Immunization.
    Pediatr Infect Dis J. 2018;37:e214-e215.
    PubMed     Abstract available
    
    
    July 2018
75. GROSSMAN Z, Hadjipanayis A, Degani A, Somekh E, et al
    Tracking Changes in Vaccine Attitudes and Decisions: Results from 2008 and 2016 Parental Surveys.
    Pediatr Infect Dis J. 2018 Jul 11. doi: 10.1097/INF.0000000000002147.
    PubMed     Abstract available
    
    
    
76. MAKWANA A, Sheppard C, Borrow R, Fry N, et al
    Characteristics of Children With Invasive Pneumococcal Disease After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine in England and Wales, 2010-2016.
    Pediatr Infect Dis J. 2018;37:697-703.
    PubMed     Abstract available
    
    
    June 2018
77. YANG Y, Yang Y, Scherpbier RW, Zhu X, et al
    Coverage of Haemophilus influenzae Type b Conjugate Vaccine for Children in Mainland China: Systematic Review and Meta-Analysis.
    Pediatr Infect Dis J. 2018 Jun 27. doi: 10.1097/INF.0000000000002132.
    PubMed     Abstract available
    
    
    
78. KADLECEK V, Borja-Tabora CF, Eder-Lingelbach S, Gatchalian S, et al
    Antibody Persistence up to 3 Years after Primary Immunization with Inactivated Japanese Encephalitis Vaccine IXIARO(R) in Philippine Children and Effect of a Booster Dose.
    Pediatr Infect Dis J. 2018 Jun 15. doi: 10.1097/INF.0000000000002124.
    PubMed     Abstract available
    
    
    
79. 
    Live Attenuated Influenza Vaccination Before 3 Years of Age and Subsequent Development of Asthma: ERRATUM.
    Pediatr Infect Dis J. 2018;37:611.
    PubMed    
    
    
    May 2018
80. PRYMULA R, Kieninger D, Feroldi E, Jordanov E, et al
    Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers in Germany and the Czech Republic.
    Pediatr Infect Dis J. 2018 May 14. doi: 10.1097/INF.0000000000002109.
    PubMed     Abstract available
    
    
    
81. MOODLEY K, Coovadia YM, Cohen C, Meiring S, et al
    Invasive Pneumococcal Disease in Neonates Prior to Pneumococcal Conjugate Vaccine Use in South Africa: 2003 - 2008.
    Pediatr Infect Dis J. 2018 May 4. doi: 10.1097/INF.0000000000002096.
    PubMed     Abstract available
    
    
    
82. 
    Vaccination in Pregnancy-Recent Developments: ERRATUM.
    Pediatr Infect Dis J. 2018;37:465.
    PubMed    
    
    
    
83. 
    Pneumococcal Immune Response in Infants Whose Mothers Received Tetanus, Diphtheria and Acellular Pertussis Vaccination During Pregnancy: ERRATUM.
    Pediatr Infect Dis J. 2018;37:450.
    PubMed    
    
    
    April 2018
84. NAZIAT H, Saha S, Islam M, Saha S, et al
    Epidemiology of Otitis Media with Otorrhea Among Bangladeshi Children: Baseline Study for Future Assessment of Pneumococcal Conjugate Vaccine Impact.
    Pediatr Infect Dis J. 2018 Apr 9. doi: 10.1097/INF.0000000000002077.
    PubMed     Abstract available
    
    
    March 2018
85. MERINO ARRIBAS JM, Carmona Martinez A, Horn M, Perez Porcuna XM, et al
    Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib and PHiD-CV When Co-Administered with MenACWY-TT in Infants: Results of an Open, Randomized Trial.
    Pediatr Infect Dis J. 2018 Mar 31. doi: 10.1097/INF.0000000000002061.
    PubMed     Abstract available
    
    
    
86. RIISE OR, Laake I, Vestrheim D, Winje BA, et al
    Preterm Children Have Higher Risk Than Full-Term Children of Invasive Pneumococcal Disease During the First Two Years of Life.
    Pediatr Infect Dis J. 2018 Mar 21. doi: 10.1097/INF.0000000000001989.
    PubMed     Abstract available
    
    
    
87. GETACHEW HB, Dahl RM, Lopman BA, Parashar UD, et al
    Rotavirus Vaccines and Health Care Utilization for Diarrhea in US Children, 2001-2015.
    Pediatr Infect Dis J. 2018 Mar 14. doi: 10.1097/INF.0000000000001988.
    PubMed     Abstract available
    
    
    
88. OH CE, Choi UY, Eun BW, Lee TJ, et al
    A Randomized, Double-Blind, Active-Controlled Clinical Trial of a Cell Culture-Derived Inactivated Trivalent Influenza Vaccine (NBP607) in Healthy Children 6 Months Through 18 Years of Age.
    Pediatr Infect Dis J. 2018 Mar 9. doi: 10.1097/INF.0000000000001973.
    PubMed     Abstract available
    
    
    
89. JACOBS K, Posa M, Spellicy W, Otero J, et al
    Adult Caregiver Influenza Vaccination Through Administration in Pediatric Outpatient Clinics: A Cocooning Healthcare Improvement Project.
    Pediatr Infect Dis J. 2018 Mar 2. doi: 10.1097/INF.0000000000001970.
    PubMed     Abstract available
    
    
    February 2018
90. NEUZIL KM
    Quantifying the Impact of Maternal Influenza Vaccination: Beyond Laboratory-Confirmed Efficacy.
    Pediatr Infect Dis J. 2018 Feb 24. doi: 10.1097/INF.0000000000001967.
    PubMed    
    
    
    
91. UBUKATA K, Morozumi M, Sakuma M, Takata M, et al
    Etiology of Acute Otitis Media and Characterization of Pneumococcal Isolates after Introduction of 13-Valent Pneumococcal Conjugate Vaccine in Japanese Children.
    Pediatr Infect Dis J. 2018 Feb 22. doi: 10.1097/INF.0000000000001956.
    PubMed     Abstract available
    
    
    
92. LI-KIM-MOY J, Wood N, Jones C, Macartney K, et al
    Impact of Fever and Antipyretic Use on Influenza Vaccine Immune Reponses in Children.
    Pediatr Infect Dis J. 2018 Feb 19. doi: 10.1097/INF.0000000000001949.
    PubMed     Abstract available
    
    
    
93. MASSEY J, Nair A, Dietz S, Snaman D, et al
    Hospital, Maternal, and Birth Factors Associated with Hepatitis B Vaccination at Birth - West Virginia, 2015.
    Pediatr Infect Dis J. 2018 Feb 16. doi: 10.1097/INF.0000000000001953.
    PubMed     Abstract available
    
    
    
94. KAORU H, Igarashi R, Hoshina T, Kojiro M, et al
    Utility of the Performance of Lumbar Puncture for Febrile Children with Status Epilepticus in the Bacterial Conjugate Vaccine Era.
    Pediatr Infect Dis J. 2018 Feb 15. doi: 10.1097/INF.0000000000001945.
    PubMed     Abstract available
    
    
    
95. OMER SB, Clark DR, Aqil AR, Tapia MD, et al
    Maternal Influenza Immunization and Prevention of Severe Clinical Pneumonia in Young Infants: Analysis of Randomized Controlled Trials Conducted in Nepal, Mali, and South Africa.
    Pediatr Infect Dis J. 2018 Feb 13. doi: 10.1097/INF.0000000000001914.
    PubMed     Abstract available
    
    
    
96. TELJEUR C, Moran PS, Harrington P, Butler K, et al
    Economic Evaluation of Selective Neonatal BCG Vaccination of High-Risk Infants in Ireland.
    Pediatr Infect Dis J. 2018 Feb 9. doi: 10.1097/INF.0000000000001891.
    PubMed     Abstract available
    
    
    
97. WITTE D, Cunliffe NA, Turner AM, Ngulube E, et al
    Safety and Immunogenicity of Seven Dosing Regimens of the Candidate RTS,S/AS01E Malaria Vaccine Integrated within an Expanded Program on Immunization Regimen: A Phase II, Single-Center, Open, Controlled Trial in Infants in Malawi.
    Pediatr Infect Dis J. 2018 Feb 9. doi: 10.1097/INF.0000000000001937.
    PubMed     Abstract available
    
    
    
98. HAVERS FP, Fry AM, Peacock G, Chen J, et al
    Influenza Vaccination Coverage in Children with Neurologic Disorders and Their Siblings, July 2006-June 2014.
    Pediatr Infect Dis J. 2018 Feb 7. doi: 10.1097/INF.0000000000001929.
    PubMed     Abstract available
    
    
    
99. LIN L, Parra MM, Sierra VY, Cespedes AS, et al
    Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine in 4-6 Year-Old Girls: Results to Month 12 from a Randomized Trial.
    Pediatr Infect Dis J. 2018 Feb 7. doi: 10.1097/INF.0000000000001871.
    PubMed     Abstract available
    
    
    
100. MENG QH, Luo J, Yang F, Shen YJ, et al
     A General Lack of IgG Against Pertussis Toxin in Chinese Pregnant Women and Newborns.
     Pediatr Infect Dis J. 2018 Feb 5. doi: 10.1097/INF.0000000000001933.
     PubMed     Abstract available
     
     
     
101. DAHL RM, Curns AT, Tate JE, Parashar UD, et al
     Effect of Rotavirus Vaccination on Acute Diarrheal Hospitalizations Among Low and Very Low Birth Weight US Infants, 2001-2015.
     Pediatr Infect Dis J. 2018 Feb 3. doi: 10.1097/INF.0000000000001930.
     PubMed     Abstract available
     
     
     
102. BERGERO PE, Fabricius G, Hozbor DF, Theeten H, et al
     Potential Impact of Changes in the Schedule for Primary Diphtheria-Tetanus Toxoids-Pertussis Immunization as Control Strategy for Pertussis.
     Pediatr Infect Dis J. 2018;37:e36-e42.
     PubMed     Abstract available
     
     
     
103. ROSENBLUT A, Rosenblut M, Garcia K, Maul X, et al
     Frequency of Acute Otitis Media in Children Under 24 Months of Age Before and After the Introduction of the 10-valent Pneumococcal Conjugate Vaccine Into the National Immunization Program in Chile.
     Pediatr Infect Dis J. 2018;37:132-134.
     PubMed     Abstract available
     
     
     January 2018
104. BURKE RM, Tate JE, Pringle KD, Patel M, et al
     Effect of Age at Vaccination on Rotavirus Vaccine Effectiveness in Bolivian Infants.
     Pediatr Infect Dis J. 2018 Jan 16. doi: 10.1097/INF.0000000000001907.
     PubMed     Abstract available
     
     
     
105. SZENBORN L, Block SL, Jackowska T, Konior R, et al
     Immune Responses to Booster Vaccination with Meningococcal ABCWY Vaccine Following Primary Vaccination with Either Investigational or Licensed Vaccines: A Phase 2 Randomized Study.
     Pediatr Infect Dis J. 2018 Jan 11. doi: 10.1097/INF.0000000000001896.
     PubMed     Abstract available
     
     
     
106. CUNNINGHAM-ERVES JL, Kelly-Taylor KD, Mayo-Gamble TL, Deakings JA, et al
     A Physician's Recommendation for HPV Vaccination: What Makes African American Mothers Compliant?
     Pediatr Infect Dis J. 2018 Jan 11. doi: 10.1097/INF.0000000000001906.
     PubMed     Abstract available
     
     
     
107. TRUCK J, Kelly S, Jawad S, Snape MD, et al
     Differences in Immunization Site Pain in Toddlers Vaccinated with Either the 10- or the 13-Valent Pneumococcal Conjugate Vaccine.
     Pediatr Infect Dis J. 2018 Jan 10. doi: 10.1097/INF.0000000000001894.
     PubMed     Abstract available
     
     
     
108. BLACK S
     Editor's Commentary: Vaccines as a Tool to Combat Antibiotic Resistance.
     Pediatr Infect Dis J. 2018;37:96.
     PubMed    
     
     
     
109. ALFONSO VH, Doshi RH, Mukadi P, Higgins SG, et al
     Prevalence of Rubella Antibodies Among Children in the Democratic Republic of the Congo.
     Pediatr Infect Dis J. 2018;37:28-34.
     PubMed     Abstract available
     
     
     
110. NDUBA V, Van't Hoog AH, Mitchell EMH, Borgdorff M, et al
     Incidence of Active Tuberculosis and Cohort Retention Among Adolescents in Western Kenya.
     Pediatr Infect Dis J. 2018;37:10-15.
     PubMed     Abstract available
     
     
     December 2017
111. EYTHORSSON E, Hrafnkelsson B, Erlendsdottir H, Atli Gudmundsson S, et al
     Decreased AOM with Treatment Failure Following Introduction of the Ten-Valent Pneumococcal Haemophilus influenzae Protein D Conjugate Vaccine.
     Pediatr Infect Dis J. 2017 Dec 22. doi: 10.1097/INF.0000000000001870.
     PubMed     Abstract available
     
     
     
112. BROPHY J, Bitnun A, Alimenti A, Lapointe N, et al
     Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in Girls Living with HIV.
     Pediatr Infect Dis J. 2017 Dec 22. doi: 10.1097/INF.0000000000001874.
     PubMed     Abstract available
     
     
     
113. BADAHDAH AM, Khatami A, Tashani M, Rashid H, et al
     Evidence for Rise in Meningococcal Serogroup C Bactericidal Antibody Titers in the Absence of Booster Vaccination in Previously Vaccinated Children.
     Pediatr Infect Dis J. 2017 Dec 8. doi: 10.1097/INF.0000000000001861.
     PubMed     Abstract available
     
     
     
114. RYBAK A, Levy C, Bonacorsi S, Bechet S, et al
     Antibiotic Resistance of Potential Otopathogens Isolated from Nasopharyngeal Flora of Children with Acute Otitis Media Before, During and After Pneumococcal Conjugate Vaccines Implementation.
     Pediatr Infect Dis J. 2017 Dec 8. doi: 10.1097/INF.0000000000001862.
     PubMed     Abstract available
     
     
     
115. PALMU AA, Lahdenkari M
     Early Vaccine-Type Pneumococcal Acute Otitis Media Does not Predispose to Subsequent Otitis When Compared to Early Acute Otitis Media Due to Other Bacterial Etiology.
     Pediatr Infect Dis J. 2017 Dec 1. doi: 10.1097/INF.0000000000001851.
     PubMed     Abstract available
     
     
     
116. LU CY, Tsai HC, Huang YC, Huang DT, et al
     A National Seroepidemiologic Survey of Pertussis Among School Children in Taiwan.
     Pediatr Infect Dis J. 2017;36:e307-e312.
     PubMed     Abstract available
     
     
     
117. MCNAIR J, Smith A, Bettinger JA, Vaudry W, et al
     Invasive Haemophilus influenzae Type b (Hib) Infections in Children with Cancer in the Era of Infant Hib Immunization Programs (1991-2014): A Report from the Canadian Immunization Monitoring Program Active.
     Pediatr Infect Dis J. 2017 Dec 1. doi: 10.1097/INF.0000000000001850.
     PubMed     Abstract available
     
     
     November 2017
118. SANTOS VS, Nobrega FA, Soares MWS, Moreira RD, et al
     Rotavirus Genotypes Circulating in Brazil Before and After the National Rotavirus Vaccine Program: A Review.
     Pediatr Infect Dis J. 2017 Nov 17. doi: 10.1097/INF.0000000000001770.
     PubMed     Abstract available
     
     
     
119. HEININGER U
     Is There A Need For A Stand-Alone Acellular Pertussis Vaccine?
     Pediatr Infect Dis J. 2017 Nov 16. doi: 10.1097/INF.0000000000001767.
     PubMed    
     
     
     
120. MOKOMANE M, Tate JE, Steenhoff AP, Esona MD, et al
     Evaluation of the Influence of Gastrointestinal Co-Infections on Rotavirus Vaccine Effectiveness in Botswana.
     Pediatr Infect Dis J. 2017 Nov 16. doi: 10.1097/INF.0000000000001828.
     PubMed     Abstract available
     
     
     
121. SUCCI RC, Krauss MR, Harris DR, Machado DM, et al
     Immunity Following Childhood Vaccinations in Perinatally HIV-Exposed Children with and without HIV Infection in Latin America.
     Pediatr Infect Dis J. 2017 Nov 14. doi: 10.1097/INF.0000000000001831.
     PubMed     Abstract available
     
     
     
122. JONES CE, Calvert A, Le Doare K
     Vaccination in Pregnancy - Recent Developments.
     Pediatr Infect Dis J. 2017 Nov 11. doi: 10.1097/INF.0000000000001822.
     PubMed    
     
     
     
123. LIVNI G, Wainstein A, Birk E, Chodick G, et al
     Influenza Vaccination Rate and Reasons for Nonvaccination in Children With Cardiac Disease.
     Pediatr Infect Dis J. 2017;36:e268-e271.
     PubMed     Abstract available
     
     
     October 2017
124. PALMU AA, Rinta-Kokko H, Nohynek H, Nuorti JP, et al
     Impact of National Ten-Valent Pneumococcal Conjugate Vaccine Programme on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland.
     Pediatr Infect Dis J. 2017 Oct 28. doi: 10.1097/INF.0000000000001810.
     PubMed     Abstract available
     
     
     
125. GARRIDO-GARCIA LM, Castillo-Moguel A, Vazquez-Rivera M, Cravioto P, et al
     Reaction of the BCG Scar in the Acute Phase of Kawasaki Disease in Mexican Children.
     Pediatr Infect Dis J. 2017;36:e237-e241.
     PubMed     Abstract available
     
     
     September 2017
126. ARYA BK, Bhattacharya SD, Sutcliffe CG, Ganaie F, et al
     Nasopharyngeal pneumococcal colonization and impact of a single dose of 13-valent pneumococcal conjugate vaccine in Indian children with HIV and their unvaccinated parents.
     Pediatr Infect Dis J. 2017 Sep 27. doi: 10.1097/INF.0000000000001800.
     PubMed     Abstract available
     
     
     
127. BERNAOLA E, Gil F, Herranz M, Gil-Setas A, et al
     Pneumococcal Vaccination and Pneumonia Associated with Pleural Effusion in a Pediatric Population.
     Pediatr Infect Dis J. 2017 Sep 20. doi: 10.1097/INF.0000000000001798.
     PubMed     Abstract available
     
     
     
128. BAXTER RP, Lewis N, Fireman B, Hansen J, et al
     Live Attenuated Influenza Vaccination Prior To Age 3 Years and Subsequent Development of Asthma: A 14-Year Follow-Up Study.
     Pediatr Infect Dis J. 2017 Sep 12. doi: 10.1097/INF.0000000000001783.
     PubMed     Abstract available
     
     
     August 2017
129. DIONNE-ODOM J, Westfall AO, Nzuobontane D, Vinikoor MJ, et al
     Predictors of Infant Hepatitis B Immunization in Cameroon: Data to Inform Implementation of a Hepatitis B Birth Dose.
     Pediatr Infect Dis J. 2017 Aug 2. doi: 10.1097/INF.0000000000001728.
     PubMed     Abstract available
     
     
     February 2017
130. NEWMAN LP, Njoroge A, Magaret A, Chohan BH, et al
     Sustained Responses to Measles Revaccination at 24 Months in HIV-Infected Children on Antiretroviral Therapy in Kenya.
     Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001572.
     PubMed     Abstract available
     
     
     August 2016
131. CHIAPPINI E, Berti E, Sollai S, Orlandini E, et al
     Dramatic Pertussis Resurgence in Tuscan Infants in 2014.
     Pediatr Infect Dis J. 2016;35:930-1.
     PubMed    
     
     
     May 2016
132. ISLAM S
     Pediatric Latent Tuberculosis: Should Travel and Foreign Birth Testing Criteria be Reassessed?
     Pediatr Infect Dis J. 2016.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: